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Abstract
In this Commentary, we aim to synthesize recent epidemiological data on tobacco and health
inequalities for New Zealand and present it in new ways. We also aim to describe both existing and
potential tobacco control responses for addressing these inequalities.
In New Zealand smoking prevalence is higher amongst Ma ¯ori and Pacific peoples (compared to
those of "New Zealand European" ethnicity) and amongst those with low socioeconomic position
(SEP). Consequently the smoking-related mortality burden is higher among these populations.
Regarding the gap in mortality between low and high socioeconomic groups, 21% and 11% of this
gap for men and women was estimated to be due to smoking in 1996–99. Regarding the gap in
mortality between Ma ¯ori and non-Ma ¯ori/non-Pacific, 5% and 8% of this gap for men and women
was estimated to be due to smoking. The estimates from both these studies are probably moderate
underestimates due to misclassification bias of smoking status. Despite the modest relative
contribution of smoking to these gaps, the absolute number of smoking-attributable deaths is
sizable and amenable to policy and health sector responses.
There is some evidence, from New Zealand and elsewhere, for interventions that reduce smoking
by low-income populations and indigenous peoples. These include tobacco taxation, thematically
appropriate mass media campaigns, and appropriate smoking cessation support services. But there
are as yet untried interventions with major potential. A key one is for a tighter regulatory
framework that could rapidly shift the nicotine market towards pharmaceutical-grade nicotine (or
smokeless tobacco products) and away from smoked tobacco.
Background
As for other countries, the distribution of disease burden
in New Zealand is far from equal [1-4]. In particular, there
are much higher rates of premature death and of serious
chronic diseases for the poorest New Zealanders, for
Ma ¯ori (the indigenous people of New Zealand), and for
Pacific peoples living in this country. Ma ¯ori adult mortal-
ity rates are at least twice those of non-Ma ¯ori in New Zea-
land. Such inequitable patterns are a concern for the
government and the health sector for the ethical reason of
ensuring justice but also because the New Zealand Gov-
ernment is committed to improving Ma ¯ori health under
the obligations of the Treaty of Waitangi (signed in 1840
between the British Crown and Ma ¯ori chiefs). In particu-
lar, Article Three of this Treaty translates into an obliga-
tion for Crown agencies to work to ensure that Ma ¯ori
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citizens enjoy the same rights as others, including the right
to good health. Section 8 of the New Zealand Public
Health and Disability Act (2000), specifically requires
health services to recognize the principles of the Treaty of
Waitangi [5].
Other arguments for reducing health inequalities are less
prominent in the New Zealand discourse, but include the
benefits of enhancing overall public health and social
cohesion and the resultant economic benefits. The latter
may arise from preventing premature deaths among work-
ers and reducing productivity losses associated with
worker illness.
Given these issues, we aimed to synthesize recent epide-
miological data on tobacco and health inequalities for
New Zealand, and to present it in new ways. We also
aimed to describe existing and potential tobacco control
responses for addressing these inequalities. Our focus is
on socioeconomic and ethnic health inequalities, and we
leave other inequalities (eg, gender, regional) to other
forums.
Social and ethnic patterning of tobacco use in 
New Zealand
Many international studies provide strong evidence that
smoking prevalence is patterned by socioeconomic posi-
tion (SEP) [6-10], and the same is true in New Zealand
[1,11,12]. There is also evidence that smoking prevalence
in this country has become more strongly patterned by
SEP over time [11,12]. One reason for this is that the
uptake of smoking by young people has declined more
steeply amongst those in the highest income level over
recent decades [13]. Ma ¯ori and Pacific peoples have a
higher smoking prevalence than non-Ma ¯ori/non-Pacific,
partly reflecting relative socioeconomic disadvantage.
Another reason for the increase in the SEP patterning of
smoking over time is probably because the quit rates
among higher-SEP New Zealanders have increased more
than for other groups [13]. The difference in quit rates by
SEP may be due to such factors as: (i) the impact of edu-
cational level on knowledge of tobacco risks and motiva-
tion and knowledge of how to quit; (ii) economic barriers
to quitting technologies (eg, the price of nicotine replace-
ment therapy was fairly high until recently and there are
still cost barriers for some pharmaceutical aids such as
bupropion); and (iii) differential levels of social and other
support for quitting. With the latter for example, second-
hand smoke exposure is higher in low-income groups
[14] and for Ma ¯ori [14,15]. Also, the first major smokefree
law (in 1990) benefited office workers more than factory
workers in terms of reducing exposure to second-hand
smoke [16].
Studies on tobacco and health inequalities in 
New Zealand
Lung cancer as a marker of historic tobacco exposure
Lung cancer is the cause of death that most directly reflects
the (historic) burden of smoking. Figure 1 shows lung
cancer mortality rates by ethnicity and household income,
for the 1980s and 1990s, as calculated from the New Zea-
land Census-Mortality Study (NZCMS) that uses linked
census and mortality datasets covering millions of person-
years of observation [17]. Lung cancer mortality rates
among Ma ¯ori were over four times the non-Ma ¯ori/non-
Pacific rate for women and over three times for men (for
1996–1999). The rates for Pacific people were also rela-
tively high (at over 2 times for men and 1.4 times for
women, compared to non-Ma ¯ori/non-Pacific). Over the
same 1981–1999 time period, the inequality in male lung
cancer mortality rates by household income persisted
despite a decline in deaths in all income groups. However,
in women there was a large increase among the low-
income group compared to a decrease among the high-
income group. Over this time period there was also an
overall increase in ethnic inequalities in mortality rates
from lung cancer (in both men and women). The authors
of this study concluded that these inequalities will proba-
bly widen in future decades – unless there is concerted
public health action. All these patterns are consistent with
differently phased tobacco epidemics [18] by ethnicity
and SEP, resulting in changing inequalities in lung cancer
over time.
The very large inequalities in lung cancer mortality by eth-
nicity are probably greater than would result alone from
historically (still large) differences in smoking prevalence,
pointing to other independent, and likely interacting, risk
factors. These may include such factors as: varying passive
smoking exposure [14,15], environmental pollution
exposure [19] and hazardous occupational exposure such
as from asbestos [20]. Diet may also be relevant to this dif-
ferential (eg, given evidence around fruit intake lowering
lung cancer risk [21]) and so might genetics given some
New Zealand evidence for variability in nicotine metabo-
lism by ethnicity [22].
Differential survival, due to differential access to care and
more advanced stage at presentation will also contribute
to ethnic inequalities in lung cancer mortality. Ma ¯ori are
more likely than non-Ma ¯ori to have lung cancer identified
at a later stage and have a lower survival rate after diagno-
sis [23]. Possible factors involved include access to spe-
cialised cancer services and the quality of care received
[24].International Journal for Equity in Health 2006, 5:14 http://www.equityhealthj.com/content/5/1/14
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Age standardised lung cancer mortality rates in New Zealand by ethnicity and household income, males and females (per  100,000 population) Figure 1
Age standardised lung cancer mortality rates in New Zealand by ethnicity and household income, males and females (per 
100,000 population). Source: Data derived from: [17]. The bars indicate 95% confidence intervals. Note the different age 
range for ethnicity and household income. The ethnic mortality rates were calculated using adjustment factors (from the 
NZCMS) for historic undercounting of Ma ¯ori and Pacific deaths [2, 3], and the income mortality rates were calculated directly 
from linked census-mortality data. Rates by household income are standardised or both age and ethnicity. Ethnicity definitions: 
The definition of ethnicity progressively changed from fractionated ethnic origin in the 1981 census (eg, 7/8 European, 1/8 
Ma ¯ori), to multiple self-identified ethnicity in 1996 elicited by the question: "Tick as many circles as you need to show which 
ethnic group(s) you belong to". This change in the question and secular trends in how people viewed their own ethnicity led to 
a disproportionate increase in the Ma ¯ori population (than expected on the basis of demographic projections alone). However, 
trends in mortality rates shown above are largely unaffected, as the numerators have been adjusted to be consistent with the 
denominators.
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The contribution of active tobacco smoking to mortality 
burden within ethnic and socioeconomic groups, and the 
mortality gap between these groups
The NZCMS includes active smoking data for the 1981–
84 and 1996–99 cohorts, allowing direct estimations of
the active smoking-related burden within and between
social groups. The measure of smoking is simply "never",
"ex-" and "current" smokers, meaning there will be inevi-
table misclassification biases of smoking that probably
lead to modest underestimates of the contribution of
active smoking.
Table 1 shows population-attributable risk percents
(PAR%) for 45–74 year olds in 1996–99 from NZCMS
output. They are the percentage reduction in all-cause
mortality that might be expected if, in a counterfactual
world, all people who were either current or ex-smokers
had actually been "never" smokers. Because of slightly
(and necessarily) different methods between the ethnic
and educational group analyses (see footnotes to Table 1),
they are not fully comparable. Nevertheless, they do
robustly point to the following conclusions:
• active smoking is a major contributor to all-cause mor-
tality in all educational and ethnic groups,
• about a quarter of 45–74 year old all-cause mortality in
each educational group is due to active smoking. This fig-
ure is slightly higher in lower educational groups, and
slightly less in higher educational groups,
• about a third of 45–74 year old all-cause mortality
among non-Ma ¯ori/non-Pacific is due to smoking. This fig-
ure is slightly higher among males, and slightly less
among females,
• a fifth to a quarter of 45–74 year old all-cause mortality
among Ma ¯ori is due to smoking.
These above estimates for Ma ¯ori are less than expected
based on previous Ministry of Health estimates that a
third of all Ma ¯ori deaths (not just 45–74 year olds where
a greater proportion of deaths will be due to smoking than
at other ages) are due to tobacco [25]. There are two key
reasons why the more recent Ministry of Health estimates
for Ma ¯ori are likely overestimates. First, other recent work
from the NZCMS finds that the relative risk of death asso-
ciated with tobacco use varies by ethnic group and over
time [26]. All-cause rate ratios (RRs) for mortality associ-
ated with smoking were significantly greater within non-
Ma ¯ori/non-Pacific than within Ma ¯ori: 2.22 compared to
1.51 respectively for men, and 2.20 compared to 1.45
respectively for women (for 1996–99). One of the likely
reasons for this rate ratio heterogeneity is the greater role
of competing non-tobacco causes of mortality among
Ma ¯ori and Pacific peoples. But other factors may also be
relevant eg, different patterns of what cigarettes are used
and how they are smoked. Second, the Ministry of Health
estimates have used the standard WHO/Peto methodol-
ogy whereby lung cancer mortality rates are used to esti-
mate the total mortality impact of smoking. However, as
mentioned above, Ma ¯ori lung cancer mortality rates are
higher than would be expected on the basis of tobacco
smoking alone, which would lead the WHO/Peto method
to overestimate the total tobacco-related mortality burden
among Ma ¯ori.
Table 1: The estimated percentage decrease (population-attributable risk percent (PAR%)) in 45–74 year old mortality rates during 
1996–99 had all current and ex-smokers actually been never smokers
Men 1996–99 Women 1996–99
Within educational group † PAR% in total 
population
PAR% within educational group PAR% in total 
population
PAR% within educational group
Nil School Post-school Nil School Post-school
(ii) All current and ex-smokers become 
never smokers in each educational group 
(ie, historically smokefree).
26% 29% 26% 23% 25% 27% 24% 23%
Within ethnic group ‡ PAR% in total 
population
PAR% within ethnic group PAR% in total 
population
PAR% within ethnic group
Ma ¯ori nMnP Ma ¯ori nMnP
(ii) All current and ex-smokers become 
never smokers in each ethnic group 
(ie, historically smokefree).
33% 21% 36% 28% 25% 28%
† Source: Table 4 from [75].
‡ Source: PAR% calculated from data in: [27].
NB: The educational PAR% estimates are calculated using Poisson rate ratios adjusted for age and ethnicity, whereas the ethnic PAR% estimates are based on age-
standardised mortality rates.
nMnP – non-Ma ¯ori non-Pacific (ie, mainly "New Zealand European" ethnicity).
See the footnotes to Figure 1 for ethnicity definitions.International Journal for Equity in Health 2006, 5:14 http://www.equityhealthj.com/content/5/1/14
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What of the contribution of smoking to gaps in mortality
between ethnic and socioeconomic groups? Poisson
regression analyses adjusting for smoking reduced the all-
cause mortality RRs for men with nil educational qualifi-
cations compared with men with post-school qualifica-
tions from 1.34 to 1.29 in 1981–84 and from 1.31 to 1.25
in 1996–99. This equated to 16% and 21% reductions in
relative inequalities respectively. The equivalent results
for women were 3% and 11% reductions in relative ine-
qualities for these time periods. Such higher mortality
rates for men and women with poorer education were due
to the impact of smoking on cardiovascular, cancer and
respiratory deaths. The patterns identified in this study
were considered to reflect the historically differential
phasing of the tobacco epidemic by sex and SEP.
The most recent NZCMS study on smoking examined its
contribution to ethnic inequalities in mortality [27]. It
found that the apparent contribution of smoking to mor-
tality differences between Ma ¯ori and non-Ma ¯ori/non-
Pacific was greatest for women in 1996–99 (8% reduction
in standardised rate difference), and had increased from
1981–84 to 1996–99 for both men (from -1% to 5%) and
women (from 3% to 8%). That is, the contribution of
smoking to ethnic gaps (in percentage terms) is notably
less than for socioeconomic gaps. But a fuller understand-
ing of this requires also considering the actual underlying
mortality rates.
Figure 2 attempts to pull together the above findings for
1996–99, and addresses the need to consider absolute
mortality rates and absolute differences in mortality rates
(as well as relative risks and percentage contributions). It
shows actual mortality rates by ethnicity and education
(partitioned by the proportions estimated to be smoking-
and non-smoking related). A floating column represent-
ing the gap in mortality rates is included (again parti-
tioned into smoking and non-smoking-related
components). The figure should be considered indicative
only. There are unavoidable differences in methodology
between: the ethnic versus educational analyses as stated
above; the determination of PAR% within ethnic and soci-
oeconomic group versus the percentage contributions to
gaps between ethnic and socioeconomic groups; and
standardisation versus regression methodologies for dif-
ferent components of analysis behind the figure. Never-
theless, there are a number of robust findings:
• mortality rates for Ma ¯ori are 2–3 times greater than non-
Ma ¯ori/non-Pacific, compared to an approximately 40%
higher mortality for people with no qualifications com-
pared to post-school qualifications;
• in absolute terms, the mortality rate attributable to smok-
ing among both Ma ¯ori and less educated groups is consid-
erably greater than among non-Ma ¯ori/non-Pacific and
post-school educated people, respectively – a different
perspective from considering the PAR% estimates in isola-
tion;
• in absolute terms, the gap in mortality rates between eth-
nic groups attributable to smoking is as great or greater
than between educational groups – a different perspective
from considering just the percentage contribution to gaps.
As mentioned already, the estimates above are likely to be
modest underestimates due to likely non-differential mis-
classification bias of smoking status. The analyses did not
include the impact of exposure to second-hand smoke,
which is more common among Ma ¯ori and lower socioe-
conomic groups [14,15]. This would mean that percent-
age contributions of active and passive smoking
combined to mortality are probably greater than given
above. Figure 2 also clearly demonstrates that ethnic gaps
in mortality not explained by smoking are much greater
than socioeconomic gaps in mortality not explained by
smoking. This points to other determinants of health (eg,
differential access to health services, racism) that must be
more important for ethnic inequalities than socioeco-
nomic inequalities in health.
What can be done to reduce health inequalities 
from tobacco in New Zealand?
Despite the apparently modest relative size of these
tobacco-related gaps, their absolute magnitude means
that eliminating them would still be very worthwhile.
Reducing these tobacco-related gaps may also be achieva-
ble given the strong evidence base for traditional tobacco
control interventions and the evidence supporting their
cost-effectiveness [28,29]. Nevertheless, many other
options for reducing health inequalities could still be pro-
gressed at the same time, including: more equitable
income redistribution in New Zealand [30], improve-
ments in educational levels, housing policies, policies to
reduce unemployment and improving access to and
through health services for low-income New Zealanders
(eg, see Figure 3). Community-level interventions to
enhance trust and promote safe environments have also
been suggested for reducing inequalities and lowering
smoking – given evidence that low social capital may be
independently associated with higher smoking prevalence
[31]. Improving work conditions may also be relevant to
reducing tobacco use disparities, given United States work
in this area [32].
These actions would also probably help reduce ethnic ine-
qualities in health, as (presumably) the type of mecha-
nisms on the pathway from ethnicity to health are similar
to those for the pathways from SEP to health (Figure 3).
The important differences, though, are the role of racismInternational Journal for Equity in Health 2006, 5:14 http://www.equityhealthj.com/content/5/1/14
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The contribution of active tobacco smoking to 45–74 yearold age-standardised mortality rates, and gaps in mortality rates,  in1996–99, by ethnicity and education (with the latter as a marker for SEP) Figure 2
The contribution of active tobacco smoking to 45–74 year old age-standardised mortality rates, and gaps in mortality rates, in 
1996–99, by ethnicity and education (with the latter as a marker for SEP). Sources: Data derived from: [75] and [27]. nMnP – 
non-Ma ¯ori non-Pacific (ie, mainly "New Zealand European" ethnicity). See the footnotes to Table 1 for ethnicity definitions.
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and ethnicity and the mix of pathway mechanisms (eg,
access to health services may be more relevant to ethnic
inequalities in New Zealand [23,24]). Reducing discrimi-
nation could potentially assist in reducing smoking rates
if the psychosocial stress associated with discrimination
contributes to smoking given the New Zealand data on
the adverse impacts of racism on health [33,34]. Also,
more specific measures are required to continue to
address past injustices (eg, through the Waitangi Tribu-
nal). Fortunately, there is evidence that gaps between
Ma ¯ori and non-Ma ¯ori are starting to decline for health,
employment, educational and income achievement
[4,35,36]. This may partly reflect specific policy initiatives
and/or be an outcome of broad economic and social
trends.
The need to reduce health inequalities attributable to
smoking is recognised in the Ministry of Health's five-year
plan for tobacco control which has specific targets for such
inequalities [37]. Some of the specific interventions that
could be considered are detailed below and some of these
are already included in the Ministry of Health's plan:
Enhanced tobacco regulation
There have been arguments in the New Zealand context
for having a Tobacco Authority type agency [38] with a
public health mandate to control the marketing of
tobacco. This approach has also been proposed by others
internationally [39,40]. Such an agency could allow the
nicotine market to be realigned to strongly favour (in
terms of price and availability) pharmaceutical-grade nic-
otine, over smoked forms of tobacco. Such a market could
also favour reduced-harmed tobacco products such as
nasal or oral snuff, though the idea of health sector
endorsement of such a market is controversial in New
Zealand. Nevertheless, a switch to snuff could plausibly
facilitate reductions in overall harm to the health of users
[41,42] and facilitate quitting [43,44] and therefore
health inequalities attributable to tobacco use. Any shift
to smokeless forms of nicotine or tobacco would also be
likely to reduce the health inequalities associated with dif-
ferent levels of exposure to second-hand smoke. A key
aspect for maximising the impact for reducing inequalities
would be the extent to which the price differential could
be managed given the suggestive evidence that low-
income and Ma ¯ori populations are more price sensitive
(see the discussion around taxation below). This shift to
alternate forms of nicotine or tobacco could also be accel-
erated by increasingly tight restrictions and raising the
price of smoked tobacco.
In the long-term however, if a large proportion of low-
income New Zealanders remained dependent on pharma-
ceutical nicotine or snuff – then this could still represent
a drain on their financial resources (if the price was not
kept relatively low). Such issues could be further explored
by modelling work and studies on the price elasticities
and acceptability of these alternative nicotine products to
low-income New Zealanders.
Finally, enhancing tobacco regulation will inevitably be a
political decision. Debate and discussion is therefore
essential not only among the tobacco control community,
but also politicians and the public at large. It is imperative
that tobacco control advocates reinforce at all times that
ridding New Zealand of tobacco smoking will benefit all
sectors of society, and reduce inequalities – a win-win sit-
uation.
Substantially enhanced comprehensive tobacco control 
policy
New Zealand could more intensively pursue all the key
components of a comprehensive tobacco control pro-
gramme (eg, tax policy, smokefree environments, and
smoking cessation support – as detailed below). All these
could be funded by increasing the relatively low level
expenditure on tobacco control, currently less than 3% of
tobacco tax revenue [45]. Added to these interventions
could be litigation against the tobacco industry by govern-
ment and a more strongly industry-focused approach to
tobacco control [46].
Tobacco taxation policy
There is some international evidence that tobacco taxes
are relatively more effective in reducing tobacco consump-
tion among low-income or poorly educated populations
[47-49]. There are also some New Zealand data to support
this differential benefit for low-income groups and Ma ¯ori
[50,51]. Other New Zealand modelling work [52] pro-
vides some justification for tobacco taxation, as it indi-
cates that the harm from smoking for low-income New
Zealanders greatly exceeds the likely harm from financial
hardship that is associated with the tax. Despite this, there
is concern regarding the potential for increased economic
hardship (with subsequent impacts on health) among
low-income groups from increased tobacco taxation in
the future. If tobacco taxes were to be increased, it would
be necessary and ethical [53] for a greater proportion of
the tax revenue to be used for smoking cessation support,
especially for Ma ¯ori, Pacific and low-income New Zea-
landers. Indeed, this country previously introduced a pro-
gramme of providing heavily subsidised nicotine
replacement therapy in the year of the last tax increase (ie,
2001).
Smokefree environments
In late 2004 a new smokefree law came into effect in New
Zealand and the evidence to date is that it is working well
[54-56]. This law covers all indoor workplaces and hospi-
tality settings which suggests that it should reduce expo-International Journal for Equity in Health 2006, 5:14 http://www.equityhealthj.com/content/5/1/14
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Simplified causal/intervention model for pathways between ethnicity and socioeconomic position to mortality Figure 3
Simplified causal/intervention model for pathways between ethnicity and socioeconomic position to mortality. * Direct inter-
personal racism and institutional racism probably has a diffuse impact on many causal processes represented by this diagram, 
including the unequal distribution of socioeconomic resources, the quantity and quality of "stress" and "psychosocial 
resources", "access to/access through the health system", and patterns of drug use – including smoking. There are New Zea-
land specific data on racism and health and racism and smoking [33, 34].
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sure to second-hand smoke among low-income workers
and patrons of venues such as bars, clubs, and casinos. In
addition, recent government-funded mass media cam-
paigns may be contributing to increasing smokefree
homes among low-income families (though post-cam-
paign follow-up data have not yet been published). There
is some indirect evidence for benefit from such campaigns
internationally on smokefree homes [57].
The prevalence of smoking in cars amongst people from
more deprived areas in New Zealand is significantly
higher than less deprived areas [58]. While some cam-
paigns have incorporated the hazard from smoking in cars
in New Zealand, these have been of low intensity. Never-
theless, laws have now been passed in other jurisdictions
(eg, Arkansas, Louisiana and Puerto Rico) and this
approach could be considered in New Zealand.
Mass media campaigns (smoking cessation)
There is evidence that mass media campaigns (both
generic and those designed by Ma ¯ori) are effective in stim-
ulating calls to the national Quitline from Ma ¯ori and
other low-income New Zealanders who are the priority
audiences for this service [59,60]. Evaluation work has
also shown that culturally appropriate mass media cam-
paigns are regarded as acceptable to a Ma ¯ori audience
[61,62]. A recently launched media campaign with a
Pacific peoples focus [63] has also successfully stimulated
increased call rates to the Quitline [Personal communica-
tion, Helen Glasgow, Director Quit Group, 28 March
2006].
Smoking cessation services
The national free-phone Quitline service has been success-
ful in reaching a Ma ¯ori audience [60,64]. The popular
uptake of heavily subsidised smoking cessation services
provided via the Quitline [65] also suggests that it is
reaching low-income New Zealanders. However, the idea
of building long-term relationships with smokers and
recruiting them as volunteers to promote smoking cessa-
tion services [66] has yet to be tried in this country.
Culturally appropriate smoking cessation services such as
the Aukati Kai Paipa services for Ma ¯ori women have been
evaluated and found to be acceptable and effective [67].
New Zealand has also had some success with running quit
and win contests [68] which may differentially appeal to
low-income smokers (although this aspect has not been
studied). A randomised controlled trial of bupropion for
Ma ¯ori smokers has reported successful smoking cessation
outcomes in this population [69].
Other countries are also trying to reduce health inequali-
ties associated with tobacco. A review of 16 studies that
aimed to reduce smoking in low-income groups found
that half of these had demonstrated effectiveness [70].
Out of another nine studies that were not actually targeted
at low-income groups, in five of these the intervention
was at least as effective in low as in high-income groups.
Nevertheless, in four of the studies, including one New
Zealand study [71], the intervention was less effective for
those in low-income groups. In particular, there is evi-
dence from the United Kingdom that smoking cessation
services are reaching disadvantaged communities [72],
that the services to such communities are qualitatively
better [73], and that these services are reducing inequali-
ties in smoking prevalence rates [74].
Conclusion
There is extensive evidence that demonstrates that smok-
ing prevalence is higher amongst those with low socioeco-
nomic position (SEP), and Ma ¯ori and Pacific peoples
(compared to those of "New Zealand European" ethnic-
ity) in the New Zealand setting. There are also many stud-
ies that indicate that the health burden attributable to
tobacco is higher amongst these populations and that the
associated relative health inequalities appear to be
increasing. The estimated contributions of smoking to
inequalities in mortality by SEP and ethnicity stand out
relative to the many other drivers of health inequalities
(ie, at 21% for SEP in men, and 8% for ethnicity in
women). This should make the tobacco contribution wor-
thy of the attention of policymakers, especially given the
evidence for the effectiveness and cost-effectiveness of
tobacco control interventions. Another reason for atten-
tion to this role for tobacco is the likelihood that, under
business as usual, tobacco will probably grow in impor-
tance as a contributor (in relative terms) to health ine-
qualities. Besides the ethical arguments for reducing
inequalities to achieve justice, there are additional argu-
ments in New Zealand for such actions. These include
obligations under the Treaty of Waitangi for the govern-
ment and the health sector and the need to address past
harms associated with colonisation.
There is some evidence from New Zealand and elsewhere
for health sector actions that reduce smoking by low-
income populations and indigenous peoples. These
include tobacco taxation, thematically appropriate mass
media campaigns, and appropriate smoking cessation
support services. There is however, major scope for
improvements in tobacco regulation and better resourc-
ing of a more intensive and comprehensive tobacco con-
trol programme in this country. In particular, there is
potential for a tighter regulatory framework that could
rapidly shift the nicotine market towards pharmaceutical-
grade nicotine (or smokeless products such as snuff) and
away from smoked tobacco.International Journal for Equity in Health 2006, 5:14 http://www.equityhealthj.com/content/5/1/14
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